EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice

Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice

(2015) Sarit Ben-Shmuel et al.   JOURNAL OF ENDOCRINOLOGY

SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer

(2015) Lei Liu et al.   PLoS One

Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion

(2014) Juan Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Regulation of the protein stability of EMT transcription factors

(2014) VM Díaz et al.   Cell Adhesion & Migration

Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer

(2013) L. R. Howe et al.   CLINICAL CANCER RESEARCH

Adipose Tissue Macrophages Function As Antigen-Presenting Cells and Regulate Adipose Tissue CD4 + T Cells in Mice

(2013) David L. Morris et al.   DIABETES

B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile

(2013) J. DeFuria et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China

(2012) Pian-Hong Zhang et al.   BMC PUBLIC HEALTH

Diabetes and cancer I: risk, survival, and implications for screening

(2012) Adedayo A. Onitilo et al.   CANCER CAUSES & CONTROL

Obesity, Energy Balance, and Cancer: New Opportunities for Prevention

(2012) S. D. Hursting et al.   Cancer Prevention Research

HDL of Patients with Type 2 Diabetes Mellitus Elevates the Capability of Promoting Breast Cancer Metastasis

(2012) Bing Pan et al.   CLINICAL CANCER RESEARCH

Estrogen Treatment After Ovariectomy Protects Against Fatty Liver and May Improve Pathway-Selective Insulin Resistance

(2012) L. Zhu et al.   DIABETES

Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model

(2012) N Alikhani et al.   ONCOGENE

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia

(2011) E J Gallagher et al.   ONCOGENE

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

(2010) Yoshihiro Takeyama et al.   CANCER LETTERS

Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes

(2010) R. Novosyadlyy et al.   CANCER RESEARCH

Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes

(2010) Yvonne Fierz et al.   ENDOCRINE-RELATED CANCER

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition

(2010) Yvonne L Chao et al.   Molecular Cancer

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

(2010) H Zhang et al.   ONCOGENE

MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

(2009) Ann F. Chambers   CANCER RESEARCH

Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes-Mediated Mammary Tumor Progression

(2009) Y. Fierz et al.   DIABETES

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer

(2008) S. Spaderna et al.   CANCER RESEARCH

Slug is a direct Notch target required for initiation of cardiac cushion cellularization

(2008) Kyle Niessen et al.   JOURNAL OF CELL BIOLOGY

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease

(2008) Meenakshi Singh et al.   MODERN PATHOLOGY

Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis

(2008) A Calvo et al.   ONCOGENE